Development and validation of a new HPLC-MS method for meglumine impurity profiling.

Area of Science:

• Pharmaceutical Analysis
• Analytical Chemistry

Background:

• Meglumine is a widely used pharmaceutical excipient, valued for its role as a counter-ion and its ability to enhance aqueous solubility.
• Despite its extensive use, the impurity profile of meglumine has not been thoroughly investigated.
• Potential impurities include reducing sugars and nitrogen-containing compounds, which necessitate robust analytical methods for detection.

Purpose of the Study:

• To develop and validate a novel High Performance Liquid Chromatography-Mass Spectrometry (HPLC-MS) method for the rapid detection and quantification of meglumine by-products.
• To specifically target reducing sugars and nitrogen impurities within meglumine samples.
• To evaluate the impurity profiles of meglumine sourced from different commercial manufacturers.

Main Methods:

• Development of a High Performance Liquid Chromatography-Mass Spectrometry (HPLC-MS) technique.
• Utilized 1-(4-aminobenzyl)-1,2,4-triazole, a reagent that reacts with carbonyl compounds, to enhance the detection of reducing sugars.
• Implemented an easy derivatization procedure prior to HPLC-MS analysis.
• Conducted method validation and analyzed impurity profiles of multiple meglumine samples.

Main Results:

• Successfully established a rapid HPLC-MS method for detecting and quantifying key meglumine impurities.
• The derivatization agent effectively improved the detection sensitivity for reducing sugars like glucose.
• Analysis revealed variations in impurity profiles among meglumine samples from different manufacturers.

Conclusions:

• The developed HPLC-MS method provides a reliable and efficient means for assessing meglumine quality.
• This method is crucial for ensuring the safety and efficacy of pharmaceutical formulations containing meglumine.
• Further investigation into meglumine impurity profiles is warranted, given the observed inter-manufacturer variability.